MARKER THERAPEUTICS, INC. Derivative, Fair Value, Net
MARKER THERAPEUTICS, INC. (MRKR) had Derivative, Fair Value, Net of $29.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:DerivativeFairValueOfDerivativeNet · last filed 2016-11-04
- 2016-09-30: Derivative, Fair Value, Net $29.00K.
- 2016-06-30: Derivative, Fair Value, Net $21.25M.
- 2016-03-31: Derivative, Fair Value, Net $29.49M.
- 2015-12-31: Derivative, Fair Value, Net $26.49M.
| Period end | Derivative, Fair Value, Net | Derivative, Fair Value, Net as first filed |
|---|---|---|
| 2016-09-30 | $29.00K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $21.25M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $29.49M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $26.49M 10-Q · filed 2016-11-04 | |
| 2015-09-30 | $32.20M 10-Q/A · filed 2016-04-14 | $7.43M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $69.96M 10-Q/A · filed 2016-04-14 | $11.67M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $8.99M 10-Q/A · filed 2016-04-14 | $9.00K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $9.00K 10-Q/A · filed 2016-04-14 | $9.41K 10-K · filed 2015-04-15 |
| 2014-09-30 | $83.52K 10-Q · filed 2014-11-19 | |
| 2013-12-31 | $722.80K 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |